Caro Socio,
in questo spazio troverai tutte gli ultimi Feed nella ricerca scientifica relativa all’antimicrobialstewardship ed alle ICA (Infezioni correlate all’assistenza)
Cliccando sul titolo del paper evidenziato nella sessione sottostante, verrai connesso all’abstract dello stesso sul portale di Pubmed
- Brave New World of Artificial Intelligence: Its Use in Antimicrobial Stewardship-A Systematic Review
- Characterization of Antibiotic Resistance in Select Tertiary Hospitals in Uganda: An Evaluation of 2020 to 2023 Routine Surveillance Data
- Attitudes, Beliefs, and Behaviors of Topical Antibiotic Prescribing among Primary Care Providers in Saudi Arabia: A Cross-Sectional Study
- Antimicrobial Stewardship in the Emergency Department Observation Unit: Definition of a New Indicator and Evaluation of Antimicrobial Use and Clinical Outcomes
- Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit all?
- Antimicrobial De-Escalation in Critically Ill Patients
- Expression of Concern: Rahman et al. An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance. Antibiotics 2022, 11, 667
- Variation in Pen-Level Prevalence of BRD Bacterial Pathogens and Antimicrobial Resistance Following Feedlot Arrival in Beef Calves
- Real-World Effectiveness of Intravenous and Oral Antibiotic Stepdown Strategies for Gram-Negative Complicated Urinary Tract Infection With Bacteremia
- Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review
- SWOT and Root Cause Analyses of Antimicrobial Resistance to Oral Antimicrobial Treatment of Cystitis
- Antibiotic Stewardship in Surgical Departments
- 2015 versus 2021: Self-Reported Preparedness to Prescribe Antibiotics Prudently among Final Year Medical Students in Sweden
- Brave New World of Artificial Intelligence: Its Use in Antimicrobial Stewardship-A Systematic Review
- Characterization of Antibiotic Resistance in Select Tertiary Hospitals in Uganda: An Evaluation of 2020 to 2023 Routine Surveillance Data